ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $133,000 | -80.1% | 3,300 | -71.6% | 0.03% | -77.0% |
Q2 2015 | $668,000 | -64.7% | 11,600 | -60.9% | 0.12% | -66.1% |
Q1 2015 | $1,891,000 | +2.8% | 29,700 | -0.3% | 0.36% | +1.1% |
Q4 2014 | $1,840,000 | +58.9% | 29,800 | -0.1% | 0.36% | +171.8% |
Q3 2014 | $1,158,000 | +12.4% | 29,823 | -0.3% | 0.13% | +17.0% |
Q2 2014 | $1,030,000 | -6.9% | 29,919 | +16.9% | 0.11% | -11.1% |
Q1 2014 | $1,106,000 | +8.1% | 25,600 | -0.4% | 0.13% | +2.4% |
Q4 2013 | $1,023,000 | +6.1% | 25,700 | 0.0% | 0.12% | -0.8% |
Q3 2013 | $964,000 | +39.7% | 25,700 | 0.0% | 0.12% | +30.5% |
Q2 2013 | $690,000 | – | 25,700 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |